Cargando…

Allergic Reactions and Cross-Reactivity Potential with Beta-Lactamase Inhibitors

Although beta-lactam allergies are an emerging focus of stewardship programs and interventions, less is publicly released regarding allergies to beta-lactamase inhibitors. This review presents and evaluates the data regarding allergic reactions with beta-lactamase inhibitors. Clavulanate, sulbactam,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stover, Kayla R., Barber, Katie E., Wagner, Jamie L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789713/ https://www.ncbi.nlm.nih.gov/pubmed/31261671 http://dx.doi.org/10.3390/pharmacy7030077

Ejemplares similares

Elbasvir/Grazoprevir: A Review of the Latest Agent in the Fight against Hepatitis C
por: Bell, Allison M., et al.
Publicado: (2016)

Impact of Obesity on Acyclovir-Induced Nephrotoxicity
por: Barber, Katie E, et al.
Publicado: (2019)

Intravenous Vancomycin Dosing in the Elderly: A Focus on Clinical Issues and Practical Application
por: Barber, Katie E., et al.
Publicado: (2016)

Fluoroquinolone Versus Nonfluoroquinolone Treatment of Bloodstream Infections Caused by Chromosomally Mediated AmpC-Producing Enterobacteriaceae
por: Gunter, Sarah Grace, et al.
Publicado: (2020)

597. Pharmacist-Led Interventions for Inpatient HIV-Related Medication Errors
por: Wingler, Mary Joyce B, et al.
Publicado: (2018)

366. Impact of Obesity in Patients With Candida Bloodstream Infections
por: Barber, Katie E, et al.
Publicado: (2018)

Docking and Molecular Dynamic of Microalgae Compounds as Potential Inhibitors of Beta-Lactamase
por: Pestana-Nobles, Roberto, et al.
Publicado: (2022)

1380. Effect of Absolute Body Weight on Clinical Outcomes of Obese Patients Treated with Cefepime
por: Wagner, Jamie L, et al.
Publicado: (2018)

1381. Impact of Total Body Weight on Efficacy of Ceftriaxone in Obese Patients
por: Wagner, Jamie L, et al.
Publicado: (2018)

Impact of Obesity on Ceftriaxone Efficacy †
por: Barber, Katie E., et al.
Publicado: (2020)

Impact of Obesity in Patients with Candida Bloodstream Infections: A Retrospective Cohort Study
por: Barber, Katie E., et al.
Publicado: (2020)

Effect of Obesity on Clinical Failure of Patients Treated With β-Lactams
por: Pinner, Nathan A, et al.
Publicado: (2021)

Ceftriaxone as an Alternative Therapy for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia after Initial Clearance of Bloodstream Infection
por: Barber, Katie E., et al.
Publicado: (2021)

Spectrum of Beta-Lactamase Inhibition by the Cyclic Boronate QPX7728, an Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases: Enhancement of Activity of Multiple Antibiotics against Isogenic Strains Expressing Single Beta-Lactamases
por: Lomovskaya, Olga, et al.
Publicado: (2020)

Time–Kill Analysis of Ceftolozane/Tazobactam Efficacy Against Mucoid Pseudomonas aeruginosa Strains from Cystic Fibrosis Patients
por: Rac, Hana, et al.
Publicado: (2017)

Omadacycline Enters the Ring: A New Antimicrobial Contender
por: Barber, Katie E., et al.
Publicado: (2018)

Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients
por: Barbier, François, et al.
Publicado: (2023)

Biochemical Characterization of QPX7728, a New Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases
por: Tsivkovski, Ruslan, et al.
Publicado: (2020)

Old and New Beta-Lactamase Inhibitors: Molecular Structure, Mechanism of Action, and Clinical Use
por: Carcione, Davide, et al.
Publicado: (2021)

Linezolid for the Treatment of Urinary Tract Infections Caused by Vancomycin-Resistant Enterococci
por: Wingler, Mary Joyce, et al.
Publicado: (2021)

Pollen Sensitization Can Increase the Allergic Reaction to Non-Cross-Reactive Allergens in a Soy-Allergic Patient
por: Briceno Noriega, Daniela, et al.
Publicado: (2023)

β-Lactamases and β-Lactamase Inhibitors in the 21st Century
por: Tooke, Catherine L., et al.
Publicado: (2019)

Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics
por: Zmarlicka, Monika T, et al.
Publicado: (2015)

Analysis of the Clinical Impact of the BioFire FilmArray Meningitis Encephalitis Panel on Antimicrobial Use and Duration of Therapy at an Academic Medical Center
por: Markovich, Kylie, et al.
Publicado: (2022)

Beta-Lactam/Beta-Lactamase Inhibitor Therapy for Potential AmpC-Producing Organisms: A Systematic Review and Meta-Analysis
por: Cheng, Matthew P, et al.
Publicado: (2019)

Ceftriaxone for the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Case Series
por: Lowe, Rachel Amanda, et al.
Publicado: (2017)

1512. Treatment of Staphylococcus aureus Bacteremia in a Pediatric Population: A Retrospective Cohort Analysis
por: Gunter, Sarah G, et al.
Publicado: (2019)

Evaluating the clinical effectiveness of new beta-lactam/beta-lactamase inhibitor combination antibiotics: A systematic literature review and meta-analysis
por: Wilson, Geneva M., et al.
Publicado: (2021)

An evaluation of antipseudomonal dosing on the incidence of treatment failure
por: Hawkins, Brandon K, et al.
Publicado: (2021)

Intravenous versus Oral Step-Down for the Treatment of Staphylococcus aureus Bacteremia in a Pediatric Population
por: Gunter, Sarah Grace, et al.
Publicado: (2022)

The Ultrabroad-Spectrum Beta-Lactamase Inhibitor QPX7728 Restores the Potency of Multiple Oral Beta-Lactam Antibiotics against Beta-Lactamase-Producing Strains of Resistant Enterobacterales
por: Lomovskaya, Olga, et al.
Publicado: (2022)

The role of beta-lactamase-producing-bacteria in mixed infections
por: Brook, Itzhak
Publicado: (2009)

Screening of inhibitors for S130G inhibitor resistant mutants of TEM type beta-lactamase
por: Baig, Mohd Hassan, et al.
Publicado: (2012)

Macrolide Allergic Reactions
por: Shaeer, Kristy M., et al.
Publicado: (2019)

Aminoglycoside Allergic Reactions
por: Childs-Kean, Lindsey M., et al.
Publicado: (2019)

Recent Advances in the Allergic Cross-Reactivity between Fungi and Foods
por: Xing, Haiyan, et al.
Publicado: (2022)

Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections
por: Bhowmick, Tanaya, et al.
Publicado: (2020)

Beta-lactamase resistance genes in Enterobacteriaceae from Nigeria
por: Awosile, Babafela B., et al.
Publicado: (2022)

Potential cross-allergic reaction from pholcodine and neuromuscular blocking agents
Publicado: (2022)

716 Risk Factors for Resistance to Beta-lactam/Beta-lactamase Inhibitors and Carbapenems in Bacteroides spp. Bacteremia
por: Smith, Janessa, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ogoqg349ah85ald10ku6a1rv2o